These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 207286)

  • 1. Opioid activity of a benzomorphan lacking an oxygen atom.
    Goldstein A; Naidu A
    Biochem Pharmacol; 1978 Apr; 27(7):1033-6. PubMed ID: 207286
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel series of potent and selective agonists at the opioid kappa-receptor.
    Costello GF; Main BG; Barlow JJ; Carroll JA; Shaw JS
    Eur J Pharmacol; 1988 Jul; 151(3):475-8. PubMed ID: 2850924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
    Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
    Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of the kappa-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens.
    Verlinde C; De Ranter C
    Eur J Pharmacol; 1988 Aug; 153(1):83-7. PubMed ID: 2850928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo.
    Rice KC; Konicki PE; Quirion R; Burke TR; Pert CB
    J Med Chem; 1983 Nov; 26(11):1643-5. PubMed ID: 6313921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of 7,8-dihydroxy-1,2,3,4,5,6,-hexahydro-2,6-methano-3-benzazocin-1-ol.
    Itoh K; Oka Y
    Chem Pharm Bull (Tokyo); 1980 Oct; 28(10):2862-7. PubMed ID: 6108800
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent progress in research on narcotic antagonists.
    Archer S; Michne WF
    Prog Drug Res; 1976; 20():45-100. PubMed ID: 189354
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans).
    Aceto MD; Harris LS; Woods JH; Katz JL; Smith CB; Medzihradsky F; Jacobson AE; Shiotani S
    Jpn J Pharmacol; 1985 Sep; 39(1):7-19. PubMed ID: 4068392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
    Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE
    J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo evidence for benzomorphan-selective receptors in rats.
    Gmerek DE; Cowan A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimorphinans as highly selective, potent kappa opioid receptor antagonists.
    Portoghese AS; Lipkowski AW; Takemori AE
    J Med Chem; 1987 Feb; 30(2):238-9. PubMed ID: 3027336
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.
    Iijima I; Minamikawa J; Jacobson AE; Brossi A; Rice KC
    J Med Chem; 1978 Apr; 21(4):398-400. PubMed ID: 206698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate receptor interactions of benzomorphans in rat brain homogenates.
    Pert CB; Snyder SH; May EL
    J Pharmacol Exp Ther; 1976 Feb; 196(2):316-22. PubMed ID: 1255479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzomorphan interactions with acetylcholine receptor complexes from Torpedo.
    King CT; Aronstam RS
    Eur J Pharmacol; 1983 Jun; 90(4):419-22. PubMed ID: 6309536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextrorphan binds to opioid receptors in guinea-pig brain membranes and is an antagonist at opioid receptors in myenteric plexus.
    Goldstein A; Naidu A
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1629-32. PubMed ID: 2155421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected antagonism in the rat vas deferens by benzomorphans which are agonists in other pharmacological tests.
    Gillan MG; Kosterlitz HW; Magnan J
    Br J Pharmacol; 1981 Jan; 72(1):13-5. PubMed ID: 6261863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.